Urogen Pharma Ltd (URGN)

R&D Expense Growth

11.15%

Quarterly · Period ending:

URGN logo

URGN R&D Expense Growth

Latest reported11.15%
URGN Quarterly R&D Growth (QoQ) (0.00% → 11.15%)
High-resolution chart · PNG

URGN r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
11.1496%
8.9633%
2.1845%
-25.9385%
-4.8161%
33.4161%
31.1669%
-26.2758%
-0.5938%
37.0908%
10.479%
-11.6885%
-7.3132%
-13.67%
10.5705%
3.5839%
-0.4411%
-2.9506%
9.7207%
-1.6579%
15.3239%
-15.2519%
21.4866%
25.9684%
-51.1333%
-17.448%
111.9397%
-5.1521%
2.7761%
-15.1679%
19.7514%
15.7259%
8.5411%
12.7348%
20.2811%
53.9578%
37.0495%
12.3103%
-17.4382%
22.2033%
-16.2153%
-61.2324%
0%
27.5121%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.